AI Technology Predicts Cardiac Events 10 Years in Advance
By HospiMedica International staff writers Posted on 05 Jun 2024 |

Current clinical guidelines recommend coronary computed tomography angiography (CCTA) as a first-line investigation for stable chest pain to identify patients who may need coronary revascularization due to obstructive coronary artery disease (CAD). However, this method often identifies many patients who do not have obstructive CAD, as well as those without any coronary atheroma, who are typically reassured and discharged without further treatment or follow-up, leaving their management and outcomes uncertain. Now, a landmark clinical study recently published in The Lancet has demonstrated the efficacy of a novel artificial intelligence (AI) technology in quantifying coronary artery inflammation and predicting cardiac events accurately.
Developed by Caristo Diagnostics (Oxford, UK), the AI-enabled CaRi-Heart technology introduces a new approach to combating heart attacks and other cardiac diseases by detecting hidden inflammation. This technology leverages advanced AI algorithms applied to routine CCTA scans, allowing it to visualize and quantify coronary inflammation, a key but often invisible factor contributing to many fatal heart attacks and strokes. The technology was tested in a landmark study analyzing data from the first 40,000 patients enrolled in the ORFAN registry, which is the largest global study assessing the ability of coronary CCTA imaging biomarkers to predict long-term cardiovascular outcomes.
The study revealed that over 80% of patients who underwent CCTA did not show obstructive CAD at the time of their scans. Despite this, the group without obstructive CAD experienced twice as many fatal and non-fatal cardiac events. Coronary inflammation, measured by Caristo’s CaRi-Heart FAI-Score, predicted these events—including heart attacks and new cases of heart failure—independently of traditional risk factors, routine clinical CCTA interpretations, calcium scoring, and plaque quantification, and it did so up to 10 years in advance. Notably, among those patients who showed no or minimal coronary plaque initially, those with the most abnormal FAI-Score results faced a 9.5-fold increase in risk for cardiac mortality and a 5.5-fold increase in risk for major adverse cardiac events (MACE).
Furthermore, Caristo’s AI-Risk model, the CaRi-Heart Risk Score, surpassed other existing clinical scores in predicting cardiac mortality. When this score was presented to clinicians, it influenced changes in management decisions for 45% of the patients, primarily driven by the need to address previously undetected coronary inflammation. This study underscores the need for robust risk prediction tools that can identify patients at risk due to inflamed coronary arteries, especially those without obstructive CAD. The CaRi-Heart technology could transform CCTA from merely a diagnostic test for selecting a minority of patients for further intervention into a preventive tool that guides the management of all patients undergoing CCTA.
"Coronary inflammation is a crucial piece of the puzzle in predicting heart attack risk,” said Keith Channon, MD, Professor of Cardiovascular Medicine at the University of Oxford, Caristo's Chief Medical Officer. “We are excited to discover that CaRi-Heart results performed exceptionally well in predicting patient cardiac events. This tool is well positioned to help clinicians identify high-risk patients with seemingly 'normal' CCTA scans."
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more